华昌化工(002274) - 2020 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2020 was ¥1,208,197,152.16, a decrease of 23.46% compared to ¥1,578,447,801.14 in the same period last year[7] - Net profit attributable to shareholders was ¥10,932,801.08, down 82.45% from ¥62,285,273.93 year-on-year[7] - Basic and diluted earnings per share were both ¥0.0115, representing an 82.42% decrease from ¥0.0654 in the same period last year[7] - Operating profit decreased by 88.37% to ¥9,705,379.52, impacted by a revenue decline of ¥370,250,648.98 due to lower product prices and reduced sales volume[15] - Net profit for the current period is ¥8,699,453.97, a significant decline of 86.0% from ¥62,314,059.19 in the previous period[41] - The company’s total profit for the current period is ¥8,718,873.30, a decrease of 89.4% from ¥82,096,472.20 in the previous period[41] - The total comprehensive income for the current period is ¥8,699,453.97, down from ¥62,314,059.19 in the previous period[43] Cash Flow - The net cash flow from operating activities was ¥928,724.44, a significant decline of 98.47% compared to ¥60,622,221.37 in the previous year[7] - Net cash flow from operating activities was -¥67,782,143.67, a decrease of 536.47% compared to the previous year, due to declining sales performance[16] - Cash inflow from operating activities totaled 733,135,390.53, down 32.5% from 1,087,090,525.61 in the prior period[51] - Cash outflow from operating activities was 800,917,534.20, a decrease of 25.2% compared to 1,071,560,856.32 in the previous period[51] - The net cash flow from investing activities improved by 90.08% to -¥1,045,634.01, driven by increased cash received from investment income[16] - The net cash flow from investing activities was -1,045,634.01, an improvement from -10,539,342.29 in the prior period[51] - The net cash flow from financing activities decreased by 37.68% to ¥62,823,610.89, primarily due to a higher repayment of bank loans compared to new borrowings[16] - The net cash flow from financing activities was 99,471,156.85, a significant increase from 732,428.47 in the previous period[57] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,730,446,420.88, an increase of 1.28% from ¥6,645,224,022.31 at the end of the previous year[7] - Total liabilities increased to CNY 3,929,883,136.17 from CNY 3,856,260,191.57, representing a growth of approximately 1.9%[31] - Current liabilities totaled CNY 3,745,893,546.17, up from CNY 3,638,004,601.57, indicating an increase of about 3.0%[31] - Total equity increased slightly to CNY 2,800,563,284.71 from CNY 2,788,963,830.74, a growth of approximately 0.4%[31] - Short-term borrowings increased to ¥2,318,971,098.00 from ¥2,203,095,670.00, reflecting a rise in financing needs[29] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 61,931[11] - The largest shareholder, Suzhou Warner Investment Co., Ltd., held 31.51% of the shares, totaling 300,059,519 shares[11] - The company did not engage in any repurchase transactions during the reporting period[11] Inventory and Receivables - Net accounts receivable decreased by 19.53% to ¥90,855,799.56 compared to the beginning of the period, while accounts receivable financing increased by 64.29% to ¥197,990,739.31[14] - Inventory increased by 16.24% to ¥651,221,498.55, primarily due to increased stock of liquid chemical products at a subsidiary[14] - Accounts receivable decreased to CNY 339,335,166.42 from CNY 373,370,512.71, a decline of about 9.1%[34] - Inventory increased to CNY 309,846,059.02 from CNY 299,332,910.10, showing a growth of approximately 3.8%[34] Expenses - Research and development expenses decreased to ¥7,233,695.34 from ¥8,086,094.68, reflecting a reduction of 10.6%[41] - Financial expenses decreased to ¥24,008,176.20 from ¥31,290,094.80, a reduction of 23.5%[41]